BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18253741)

  • 1. Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.
    Caffier PP; Marzahn U; Franke A; Sudhoff H; Jovanovic S; Haisch A; Sedlmaier B
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1179-88. PubMed ID: 18253741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic effect of argon and diode laser on cholesteatoma cell cultures after intravital staining with absorption enhancers.
    Sedlmaier B; Franke A; Sudhoff H; Jovanovic S; Haisch A
    Lasers Med Sci; 2005; 19(4):248-56. PubMed ID: 15772874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotargeted photodynamic therapy for cholesteatoma: in vitro results with anti-EGFR-coated indocyanine green nanocapsules.
    Gluth MB; Kaufmann YC; Dornhoffer JL; Ferguson S
    Otol Neurotol; 2015 Jan; 36(1):76-81. PubMed ID: 25514782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observation and mechanism study of bladder wound healing after transurethral holmium laser resection of bladder tumor.
    Han S; Dong K; Shen M; Wang X; Jiang W; Zhao W; Xu D
    Lasers Med Sci; 2019 Aug; 34(6):1217-1227. PubMed ID: 30796543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock proteins in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis.
    Broekaert D; Cornille A; Eto H; Leigh I; Ramaekers F; Van Muijen G; Coucke P; De Bersaques J; Kluyskens P; Gillis E
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):39-51. PubMed ID: 2453971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical imaging with a high-resolution microendoscope to identify cholesteatoma of the middle ear.
    Levy LL; Jiang N; Smouha E; Richards-Kortum R; Sikora AG
    Laryngoscope; 2013 Apr; 123(4):1016-20. PubMed ID: 23299781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.
    Liu W; Yin T; Ren J; Li L; Xiao Z; Chen X; Xie D
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):265-73. PubMed ID: 23463347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR expression in acquired middle ear cholesteatoma in children and adults.
    Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
    Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
    Olszewska E; Sudhoff H
    Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
    Kim HJ; Tinling SP; Chole RA
    J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
    Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
    Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A; Sussman ZM; Lawson D; Cohen C
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
    Huang CC; Chen CT; Huang TS; Shinoda H
    Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curved adjustable fibre-optic diode laser in microscopic cholesteatoma surgery: description of use and review of the relevant literature.
    McCaffer CJ; Pabla L; Watson C
    J Laryngol Otol; 2018 Apr; 132(4):360-363. PubMed ID: 29517472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.